Actinium Pharmaceuticals, Inc. Uncategorized Contracts & Agreements
42 Contracts & Agreements
- Fourth Amendment to the Actinium Pharmaceuticals, Inc. 2019 Plan (Filed With SEC on December 30, 2022)
- Second Amendment to the Actinium Pharmaceuticals, Inc. 2019 Plan (Filed With SEC on November 9, 2021)
- Description of securities (Filed With SEC on March 31, 2021)
- Amendment to the Actinium Pharmaceuticals, Inc. 2019 Plan (Filed With SEC on November 20, 2020)
- Actinium Pharmaceuticals, Inc. 2019 Plan (Filed With SEC on November 20, 2020)
- Indemnity Agreement, dated April 27, 2018, by and between Jeffrey W. Chell and Actinium Pharmaceuticals, Inc (Filed With SEC on May 1, 2018)
- Director Agreement, dated April 27, 2018, by and between Jeffrey W. Chell and Actinium Pharmaceuticals, Inc (Filed With SEC on May 1, 2018)
- Offer Letter, effective January 31, 2018, between Anil Kapur and Actinium Pharmaceuticals, Inc (Filed With SEC on March 16, 2018)
- Offer Letter, effective January 2, 2018, between Dale L. Ludwig and Actinium Pharmaceuticals, Inc (Filed With SEC on March 16, 2018)
- Dealer-Manager Agreement, dated February 15, 2018, between Maxim Group LLC and Actinium Pharmaceuticals, Inc (Filed With SEC on February 15, 2018)
- Agreement, dated June 6, 2017, by and between Actinium Pharmaceuticals, Inc. and Sergio Traversa (Filed With SEC on August 4, 2017)
- Offer Letter; dated May 26, 2017, by and between Actinium Pharmaceuticals, Inc. and Dr. Nitya G. Ray (Filed With SEC on August 4, 2017)
- Indemnity Agreement, dated May 15, 2017, by and between Actinium Pharmaceuticals, Inc. and Steve OLoughlin (Filed With SEC on May 15, 2017)
- INDEMNIFICATIONAGREEMENT (Filed With SEC on March 28, 2017)
- INDEMNIFICATIONAGREEMENT (Filed With SEC on March 16, 2017)
- ACTINIUMPHARMACEUTICALS, INC. 8,000,000 Shares CommonStock ($0.001par value) UnderwritingAgreement (Filed With SEC on September 29, 2016)
- Effective Date: August 6, 2015 (Filed With SEC on August 7, 2015)
- SUBSCRIPTIONAGREEMENT (Filed With SEC on June 5, 2015)
- AGREEMENT (Filed With SEC on May 8, 2015)
- ACTINIUMPHARMACEUTICALS, INC. AMENDED AND RESTATED 2013 EQUITYINCENTIVE PLAN (Filed With SEC on March 16, 2015)
- EffectiveDate: August 11, 2014 (Filed With SEC on March 16, 2015)
- To subscribe for Units in the private offering of ACTINIUM PHARMACEUTICALS, INC. (Filed With SEC on January 31, 2014)
- FORM OF LOCK-UP AGREEMENT (Filed With SEC on January 31, 2014)
- LOCK-UP LETTER AGREEMENT (Filed With SEC on August 22, 2013)
- CLINICAL TRIAL AGREEMENT (SK#11731) (Filed With SEC on January 4, 2013)
- Sloan-Kettering Institute for Cancer Research 1275 York Avenue New York, NY 10021 (Filed With SEC on January 4, 2013)
- Actinium Pharmaceuticals, Inc. (Filed With SEC on January 4, 2013)
- AMENDMENT No. 1 TO RESEARCH AGREEMENT (Filed With SEC on January 4, 2013)
- CLINICAL TRIAL AGREEMENT (Filed With SEC on January 4, 2013)
- Proposal for Actinium Pharmaceuticals, Inc. 225Ac-Labeling of HuM195 March 30, 2007 (Filed With SEC on January 4, 2013)
- Project Agreement Number: 1 Aptiv Project Number: ACTI-1903 (Filed With SEC on January 4, 2013)
- CLINICAL TRIAL AGREEMENT (Filed With SEC on January 4, 2013)
- CLINICAL TRIAL AGREEMENT (Filed With SEC on January 4, 2013)
- CLINICAL TRIAL AGREEMENT (Filed With SEC on January 4, 2013)
- Actinium Pharmaceuticals, Inc. July 21, 2012 (Filed With SEC on January 4, 2013)
- Actinium Pharmaceuticals, Inc. (Filed With SEC on January 4, 2013)
- CLINICAL TRIAL AGREEMENT (Filed With SEC on January 4, 2013)
- An Operating Division of Averion International Corp. *CONFIDENTIAL* (Filed With SEC on January 4, 2013)
- Monday, April 14, 2003 (3).max (Filed With SEC on January 4, 2013)
- LAIDLAW & COMPANY (UK) LTD. 90 Park Avenue41 Dover StreetNew York, NY 10016W1S 4NS London * Member FINRA, SIPC* *Incorporated in England & Wales: Company No. 3870324* *Authorized... (Filed With SEC on January 4, 2013)
